• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dynamic folding modulation generates FGF21 variant against diabetes.动态折叠调节产生针对糖尿病的 FGF21 变体。
EMBO Rep. 2021 Jan 7;22(1):e51352. doi: 10.15252/embr.202051352. Epub 2020 Dec 9.
2
Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.胰岛素抵抗与骨骼肌中FGF21信号转导受损之间的关联。
Endocrine. 2016 Jul;53(1):97-106. doi: 10.1007/s12020-015-0845-x. Epub 2016 Jan 12.
3
Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.FGF21类似物、利拉鲁肽和甘精胰岛素治疗2型糖尿病的药理疗效
J Diabetes Complications. 2017 Apr;31(4):726-734. doi: 10.1016/j.jdiacomp.2017.01.008. Epub 2017 Jan 21.
4
The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM).二甲双胍对 2 型糖尿病(T2DM)中成纤维细胞生长因子 21 的潜在影响。
Inflammopharmacology. 2023 Aug;31(4):1751-1760. doi: 10.1007/s10787-023-01255-4. Epub 2023 Jun 19.
5
Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.成纤维细胞生长因子 21 通过调节 AMPK 信号通路和脂代谢保护胰岛β细胞免受脂毒性损伤。
Clin Sci (Lond). 2019 Oct 15;133(19):2029-2044. doi: 10.1042/CS20190093.
6
Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319.基于成纤维细胞生长因子 21 的临床候选药物 LY2405319 的合理设计。
PLoS One. 2013;8(3):e58575. doi: 10.1371/journal.pone.0058575. Epub 2013 Mar 11.
7
Impact of FGF21 on glycemic control.成纤维细胞生长因子21对血糖控制的影响。
Horm Mol Biol Clin Investig. 2017 Jun 3;30(2):/j/hmbci.2017.30.issue-2/hmbci-2017-0001/hmbci-2017-0001.xml. doi: 10.1515/hmbci-2017-0001.
8
FGF21 Normalizes Plasma Glucose in Mouse Models of Type 1 Diabetes and Insulin Receptor Dysfunction.成纤维细胞生长因子 21 可使 1 型糖尿病和胰岛素受体功能障碍模型小鼠的血浆葡萄糖水平恢复正常。
Endocrinology. 2021 Sep 1;162(9). doi: 10.1210/endocr/bqab092.
9
FGF21 gene therapy as treatment for obesity and insulin resistance.成纤维细胞生长因子 21 基因治疗肥胖和胰岛素抵抗。
EMBO Mol Med. 2018 Aug;10(8). doi: 10.15252/emmm.201708791.
10
Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history.妊娠期糖尿病患者血清成纤维细胞生长因子 19 和 21 浓度:与胰岛素抵抗、脂联素和多囊卵巢综合征病史的关系。
PLoS One. 2013 Nov 19;8(11):e81190. doi: 10.1371/journal.pone.0081190. eCollection 2013.

引用本文的文献

1
Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications.成纤维细胞生长因子:作用及新兴治疗应用
Curr Drug Targets. 2025;26(8):551-570. doi: 10.2174/0113894501351461250301072444.
2
Overexpression and biophysical and functional characterization of a recombinant FGF21.重组FGF21的过表达及其生物物理和功能特性分析
Biophys Rep (N Y). 2025 Mar 12;5(1):100198. doi: 10.1016/j.bpr.2025.100198. Epub 2025 Jan 29.
3
Novel FGF21 analogues through structure-based optimization for therapeutic development.通过基于结构的优化开发新型成纤维细胞生长因子21(FGF21)类似物用于治疗。
Acta Biochim Biophys Sin (Shanghai). 2024 Dec 24;57(4):582-587. doi: 10.3724/abbs.2024227.
4
The role of nonmyocardial cells in the development of diabetic cardiomyopathy and the protective effects of FGF21: a current understanding.非心肌细胞在糖尿病心肌病发展中的作用及 FGF21 的保护作用:当前认识。
Cell Commun Signal. 2024 Sep 26;22(1):446. doi: 10.1186/s12964-024-01842-0.
5
Exploring endocrine FGFs - structures, functions and biomedical applications.探索内分泌成纤维细胞生长因子——结构、功能及生物医学应用
Int J Biochem Mol Biol. 2024 Aug 25;15(4):68-99. doi: 10.62347/PALK2137. eCollection 2024.
6
FGF21 overexpression alleviates VSMC senescence in diabetic mice by modulating the SYK-NLRP3 inflammasome-PPARγ-catalase pathway.成纤维细胞生长因子21(FGF21)过表达通过调节脾酪氨酸激酶(SYK)-NLR家族含pyrin结构域蛋白3(NLRP3)炎性小体-过氧化物酶体增殖物激活受体γ(PPARγ)-过氧化氢酶途径减轻糖尿病小鼠血管平滑肌细胞(VSMC)衰老。
Acta Biochim Biophys Sin (Shanghai). 2024 Jun 25;56(6):892-904. doi: 10.3724/abbs.2024032.
7
Computer-aided engineering of stabilized fibroblast growth factor 21.稳定型成纤维细胞生长因子21的计算机辅助工程
Comput Struct Biotechnol J. 2024 Feb 7;23:942-951. doi: 10.1016/j.csbj.2024.02.001. eCollection 2024 Dec.
8
Overexpression and Purification of Mitogenic and Metabolic Fibroblast Growth Factors.有丝分裂原和代谢性成纤维细胞生长因子的过表达和纯化。
Methods Mol Biol. 2024;2762:151-181. doi: 10.1007/978-1-0716-3666-4_10.
9
Mechanisms of Fibroblast Growth Factor 21 Adsorption on Macroion Layers: Molecular Dynamics Modeling and Kinetic Measurements.成纤维细胞生长因子 21 在大离子层上吸附的机制:分子动力学模拟和动力学测量。
Biomolecules. 2023 Nov 26;13(12):1709. doi: 10.3390/biom13121709.
10
Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents.2 型糖尿病靶点和治疗药物研究进展。
Int J Mol Sci. 2023 Aug 29;24(17):13381. doi: 10.3390/ijms241713381.

本文引用的文献

1
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic.成纤维细胞生长因子 21 在代谢性疾病中的治疗潜力:从实验室到临床。
Nat Rev Endocrinol. 2020 Nov;16(11):654-667. doi: 10.1038/s41574-020-0386-0. Epub 2020 Aug 6.
2
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes.慢性脂肪组织炎症:连接肥胖与胰岛素抵抗及2型糖尿病
Front Physiol. 2020 Jan 29;10:1607. doi: 10.3389/fphys.2019.01607. eCollection 2019.
3
Fibroblast growth factor 21 in non-alcoholic fatty liver disease.成纤维细胞生长因子 21 在非酒精性脂肪性肝病中的作用。
Metabolism. 2019 Dec;101:153994. doi: 10.1016/j.metabol.2019.153994. Epub 2019 Oct 28.
4
Identification of a crucial amino acid responsible for the loss of specifying FGFR1-KLB affinity of the iodinated FGF21.鉴定出一个关键的氨基酸,该氨基酸负责使碘化 FGF21 失去与 FGFR1-KLB 的特异性亲和力。
J Cell Physiol. 2019 Mar;234(3):2500-2510. doi: 10.1002/jcp.26780. Epub 2018 Oct 14.
5
A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling.系统剖析决定β-Klotho 和 FGF 相互作用及信号转导的序列元件。
Sci Rep. 2018 Jul 23;8(1):11045. doi: 10.1038/s41598-018-29396-5.
6
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing.具有最佳药物学和药代动力学特性的糖基化长效 FGF21 变体,可实现每周至每两周一次的皮下给药。
Sci Rep. 2018 Mar 9;8(1):4241. doi: 10.1038/s41598-018-22456-w.
7
Improving hyperglycemic effect of FGF-21 is associated with alleviating inflammatory state in diabetes.改善 FGF-21 的高血糖效应与缓解糖尿病中的炎症状态有关。
Int Immunopharmacol. 2018 Mar;56:301-309. doi: 10.1016/j.intimp.2018.01.048. Epub 2018 Feb 3.
8
Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat.成纤维细胞生长因子21通过特异性增加皮下脂肪来提高胰岛素敏感性。
Nat Commun. 2018 Jan 18;9(1):272. doi: 10.1038/s41467-017-02677-9.
9
α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling.α-klotho 是 FGF23 激素信号的非酶分子支架。
Nature. 2018 Jan 25;553(7689):461-466. doi: 10.1038/nature25451. Epub 2018 Jan 17.
10
Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.β-klotho 结构揭示了内分泌 FGF 信号的“邮政编码”样机制。
Nature. 2018 Jan 25;553(7689):501-505. doi: 10.1038/nature25010. Epub 2018 Jan 17.

动态折叠调节产生针对糖尿病的 FGF21 变体。

Dynamic folding modulation generates FGF21 variant against diabetes.

机构信息

High Magnetic Field Laboratory, CAS Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, China.

School of Biotechnology & Food Engineering, Hefei University of Technology, Hefei, China.

出版信息

EMBO Rep. 2021 Jan 7;22(1):e51352. doi: 10.15252/embr.202051352. Epub 2020 Dec 9.

DOI:10.15252/embr.202051352
PMID:33295692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7788455/
Abstract

Fibroblast growth factor 21 (FGF21) is a regulator of glucose and lipid metabolism. It has been widely considered as a promising candidate for the treatment of type 2 diabetes mellitus (T2DM) and other related metabolic disorders. However, lack of structural and dynamic information has limited FGF21-based drug development. Here, using nuclear magnetic resonance (NMR) spectroscopy, we determine the structure of FGF21 and find that its non-canonical flexible β-trefoil conformation affects the folding of β2-β3 hairpin and further overall protein stability. To modulate folding dynamics, we designed an FGF21-FGF19 chimera, FGF21 . As expected, FGF21 shows better thermostability without inducing hepatocyte proliferation. Functional characterization of FGF21 shows its better insulin sensitivity, reduced inflammation in 3T3-L1 adipocytes, and lower blood glucose and insulin levels in ob/ob mice compared with wild type. Our dynamics-based rational design provides a promising approach for FGF21-based therapeutic development against T2DM.

摘要

成纤维细胞生长因子 21(FGF21)是调节葡萄糖和脂质代谢的物质。它被广泛认为是治疗 2 型糖尿病(T2DM)和其他相关代谢紊乱的有前途的候选药物。然而,缺乏结构和动态信息限制了基于 FGF21 的药物开发。在这里,我们使用核磁共振(NMR)光谱法确定了 FGF21 的结构,发现其非典型的灵活 β-三叶折叠构象影响β2-β3 发夹的折叠,进而影响整体蛋白质稳定性。为了调节折叠动力学,我们设计了 FGF21-FGF19 嵌合体,即 FGF21。正如预期的那样,FGF21 表现出更好的热稳定性,而不会诱导肝细胞增殖。FGF21 的功能特征表明,与野生型相比,其胰岛素敏感性更好,3T3-L1 脂肪细胞中的炎症减少,ob/ob 小鼠的血糖和胰岛素水平降低。我们基于动力学的合理设计为基于 FGF21 的 T2DM 治疗开发提供了一种有前途的方法。